Difference between revisions of "Cancamon"
(Created page with "Cancamon is a non-scientific common name that may refer to a number of plant species and varieties. == Nomenclature== === Other Names:=== == Historical Use of Cancamon== === C...") |
(Added Western Medicine category) |
||
| Line 31: | Line 31: | ||
===Pregnancy and Breastfeeding=== | ===Pregnancy and Breastfeeding=== | ||
===Adverse Effects=== | ===Adverse Effects=== | ||
| + | [[Category:Western Medicine]] | ||
Revision as of 11:52, 8 April 2015
Cancamon is a non-scientific common name that may refer to a number of plant species and varieties.
Contents
Nomenclature
Other Names:
Historical Use of Cancamon
Cancamon in Traditional Chinese Medicine
Description
Historical Use of Cancamon in Western Medicine
Quote Paraph: "Of the remaining fourteen substances, ten are without any definite magic connotation, although the manner of their action is not explained. They are: cancamon…"
Sec Auth: Temkin O
Title: The Falling Sickness. Second Edition, Revised, Softshell Books edition, 1994
Page: 80
Source: The Falling Sickness, Second Edition, Revised, Softshell Books edition, 1994,Owsei Temkin
Complete: Temkin O. The falling sickness: a history of epilepsy from the Greeks to the beginnings of modern neurology. London: Johns Hopkins Univ. Press, 2 Revised Edition, (Softshell Books) ; 1994. p. 80.
Primary Source: 536 Cf. Dioscurides (282), ed. Wellmann, vol. 1, p. 28, 13.
Background
Synonymns for Cancamon
Patent Medicines and Medicines with Multiple Ingredients that include Cancamon
Pharmaceutical Information
Chemical Constituents
Evidence or the Use of Cancamon in the Treatment of Epilepesy
Basic Science
Animal Studies
Cohort, Case-Control and Non-Randomized Trials
Randomized Controlled Trials
Meta-Analysis
1st Five Results: pubmed search
Carol Blixen, Gena Ghearing, Owen Wade, Kari Colon-Zimmerman, Maegan Tyrrell, Martha Sajatovic
Engaging stakeholders in the refinement of an evidence-based remotely delivered epilepsy self-management program for rural populations.
Epilepsy Behav: 2021, 118;107942
[PubMed:33845345]
[WorldCat.org]
[DOI]
(I a)
Gernot Hlauschek, Benjamin Sinclair, Benjamin Brinkmann, Joshua Fuge, Patrick Kwan, Terence J O'Brien, Lucy Vivash
The effect of injection time on rates of epileptogenic zone localization using SISCOM and STATISCOM.
Epilepsy Behav: 2021, 118;107945
[PubMed:33845344]
[WorldCat.org]
[DOI]
(I a)
N Lu, H Liu, Y Huang
A survey of values and related factors among 200 guardians of children with epilepsy.
Public Health: 2021, 194;17-18
[PubMed:33845274]
[WorldCat.org]
[DOI]
(I a)
Andrew J Roebuck, Quentin Greba, Anna-Maria Smolyakova, Mariam Alaverdashvili, Wendie N Marks, Sumanta Garai, Samantha L Baglot, Gavin Petrie, Stuart M Cain, Terrance P Snutch, Ganesh A Thakur, Matthew N Hill, John G Howland, Robert B Laprairie
Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.
Neuropharmacology: 2021;108553
[PubMed:33845076]
[WorldCat.org]
[DOI]
(I a)
M L Eckard, S G Kinsey
Gabapentin attenuates somatic signs of precipitated THC withdrawal in mice.
Neuropharmacology: 2021;108554
[PubMed:33845073]
[WorldCat.org]
[DOI]
(I a)
